THE FRAIL-D STUDY: ASSESSING FRAILTY AS A RISK FACTOR FOR OUTCOMES IN PATIENTS WITH IMPLANTABLE CARDIOVERTER DEFIBRILLATORS FOR PRIMARY PREVENTION